Vascular Biogenics Ltd.
METHODS OF ANTI-TUMOR THERAPY

Abstract:

The invention provides methods for inducing or improving an anti-tumor response in a subject having a tumor, comprising administering to the subject a priming dose of a vector which comprises a Fas-chimera gene operably linked to an endothelial cell specific promoter, wherein the priming dose of the vector is administered prior to surgical removal of the tumor or a portion thereof.